喜炎平注射液联合利巴韦林治疗80例小儿病毒性发热临床疗效分析

目的：探讨喜炎平注射液联合利巴韦林治疗小儿病毒性肺炎和小儿病毒性肠炎伴发热患儿的临床治疗效果及应用价值。方法：选择我院儿科2012年1月-2013年1月收治的小儿病毒性肺炎和小儿病毒性肠炎惠儿80例，所有患儿伴有不同程度的发热，将所有患儿随机分为2组，对照组40例给予单纯利巴韦林治疗，观察组40例在给予利巴韦林治疗的基础上给予患儿喜炎平注射液治疗，比较两种治疗方案对病毒性肺炎和病毒性肠炎的治疗效果及两组小儿的退热时间及住院时间。结果：观察组患儿病毒性肺炎和病毒性肠炎的治疗有效率分别为96％、93．33％明显高于对照组患儿70．83％和62．50％，差异有统计学意义（P〈0．05）。观察组患儿退热时间及住院时间均短于对照组，经统计学分析比较，差异有统计学意义（P〈0．05）。两组不良反应发生率比较，差异无统计学意义（P〉0．05）。结论：采用喜炎平注射液联合利巴韦林治疗小儿病毒性肺炎和小儿病毒性肠炎伴发热疗效显著，能够缩短退热时间和住院时间，值得在临床大力推广使用。

Treatment Analysis on Therapeutic Effect of Xiyanping Injection Combined with Ribavirin on 80 Cases Children Patients with Infantile Viral Fever

Objective： To investigate the therapeutic effect of Xiyanping Injection and ribavirin on fever induced by Infantile Viral Pneumonia and infantile virus enteritis. Methods： 80 cases with Infantile Viral Pneumonia and infantile virus enteritis were selected in our hospital from January 2010 to January 2013. All the children were of fever, and were divided into 2 groups randomly： the eontrol group （40 cases） were treated with ribavirin; the observation group （40 cases） were treated with Xiyanping Injection and ribavirin. The therapeutic effect and hospital staying time were compared. Results： The total effective rate of Infantile Viral Pneumonia and infantile virus enteritis in observation group were 96% and 93.33%, respectively, and were significantly higher than those in the control group （70.83% and 62.50%, P 〈0.05）, the hospital staying time and antipyretic time of observation group were shorter than those in control group （P〈0.05）. Conclusion： The therapeutic effect of Xiyanping Injection and ribavirin on fever induced by Infantile Viral Pneumonia and infantile virus enteritis was effective and worthy for applying.